Back | Next |
home / stock / vir / vir message board
Subject | By | Source | When |
---|---|---|---|
Full of crap haha | Srhogan1984 | investorshub | 01/27/2021 2:55:41 AM |
* * $VIR Video Chart 01-26-2021 * * | ClayTrader | investorshub | 01/26/2021 11:18:56 PM |
znewcar1: VIR 74% v11,4M c77.38 f127M H78.28 | znewcar1 | investorshangout | 01/26/2021 9:36:20 PM |
Sounds like a short to me. You need | Srhogan1984 | investorshub | 01/26/2021 9:06:52 PM |
Today's move is somewhat scary in the context | DewDiligence | investorshub | 01/26/2021 6:18:52 PM |
VIR(+40% undeservedly, $IMO)on interim phase-1 data for$ VIR-3434 in HBV: | DewDiligence | investorshub | 01/26/2021 6:14:35 PM |
Not really. It's just a phase-2 trial, not | DewDiligence | investorshub | 01/12/2021 2:05:26 PM |
$GILD,$ VIR collaborate on phase-2 HBV trial: | DewDiligence | investorshub | 01/12/2021 2:02:19 PM |
Huge news! | Srhogan1984 | investorshub | 01/12/2021 1:49:06 PM |
What is happening here | Srhogan1984 | investorshub | 09/02/2020 3:39:40 AM |
$VIR starts phase-1 trial of $VIR-3434: | DewDiligence | investorshub | 05/27/2020 2:35:19 PM |
znewcar1: VIR 32% v5,5M c40.10 f117,9M H42.4 gap up then BO R@40.6 dip S@38.1 then HOD and back to S | znewcar1 | investorshangout | 05/18/2020 8:48:27 PM |
* * $VIR Video Chart 05-18-2020 * * | ClayTrader | investorshub | 05/18/2020 8:31:16 PM |
$VIR 1Q20 results3/31/20 cash=$361.8M: | DewDiligence | investorshub | 05/12/2020 8:25:49 PM |
$VIR reports interim phase-2 data in HBV: | DewDiligence | investorshub | 04/15/2020 10:34:58 PM |
nobody pumping this here lol? | Cornball69 | investorshub | 04/13/2020 4:43:14 PM |
Biocentury expounds on$ VIR-$GSK hookup: | DewDiligence | investorshub | 04/07/2020 2:34:58 AM |
znewcar1: VIR 26% v3,6M c36.70 f109,7M PreMH@42 HOD@39.8 S32.25 | znewcar1 | investorshangout | 04/06/2020 8:57:50 PM |
When Glaxo runs a deal with any company, | Pugsieboy | investorshub | 04/06/2020 3:17:12 PM |
When YOU post in any thread $RUN LIKE HELL! | Rocket10 | investorshub | 04/06/2020 3:11:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide financial results for the second quarter ended June 30, 2024, on August 1, 2024. The Company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on August 1, 2024. Financial results will ...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
2024-07-08 10:47:03 ET BITX (BITX) BITX is trading DOWN for the last 4 days, and it at trading at $27.48 with volume of 3,908,355 and a one day change of $-0.37 (-1.33%). BITX has a 52-week low of 0.00 and a 52-week high of $0.00. The business's 50-day moving average price is $45.40...